Vertex Pharmaceuticals (VRTX)

Cost of Revenue

$489.20M

Quarterly · Period ending: · USD

VRTX logo

VRTX Cost of Revenue

Latest reported$489.20M
VRTX Quarterly Cost of Revenue ($0.00 → $489.20M)
High-resolution chart · PNG

VRTX cost of revenue history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Vertex Pharmaceuticals Cost of Revenue — Quarterly (USD)
Period endingCost of Revenue (USD)
489,200,000
392,800,000
466,000,000
414,800,000
407,500,000
363,000,000
423,400,000
392,600,000
371,900,000
342,600,000
368,000,000
318,700,000
308,600,000
266,900,000
283,300,000
289,400,000
261,800,000
245,800,000
247,400,000
236,512,000
227,972,000
192,329,000
203,101,000
186,182,000
184,520,000
162,497,000
185,012,000
131,914,000
135,740,000
95,092,000
122,289,000
111,255,000
104,382,000
71,613,000
84,052,000
72,874,000
71,205,000
46,988,000
60,482,000
54,077,000
45,252,000
50,649,000
64,415,000
31,960,000
16,860,000
12,307,000
14,027,000
14,184,000
17,300,000
15,476,000
22,264,000
27,339,000
37,931,000
42,743,000
87,715,000
38,536,000
114,423,000
39,211,000
30,127,000
38,406,000
9,306,000
2,666,000
3,049,000
3,228,000
3,086,000
3,367,000
3,647,000
3,712,000
3,267,000
3,576,000
4,215,000
4,194,000
3,701,000
3,576,000
3,672,000
3,562,000
3,401,000
3,269,000
3,177,000
3,113,000
2,885,000
2,995,000
2,783,000
2,796,000
2,489,000
2,030,000
2,009,000
1,466,000
1,328,000
846,000
-4,230,000
1,651,000
1,538,000
3,515,000
6,601,000
6,577,000
6,462,000
8,641,000
9,670,000
10,663,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.